Platelet count: >= 50,000/mm^3, transfusion independent (no platelet transfusions within 1 week)
62.0
Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
77.0
For patients with solid tumors without known bone marrow involvement: platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
154.0
Platelets >= 100,000/mm^3 transfusion independent (no platelet transfusion one week prior to enrollment)
40.0
Platelet count >= 75,000 and transfusion independent
28.0
For patients with solid tumors without known bone marrow involvement: platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
148.0
Platelet count >= 75,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
484.0
* Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
81.0
Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
67.0
For patients with solid tumors without known bone marrow involvement: * Peripheral absolute neutrophil count (ANC) >= 1000/mm^3* Platelet count >= 75,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)* Hemoglobin >= 8.0 g/dl at baseline (may receive packed red blood cell [PRBC] transfusions)
65.0
Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
36.0
Platelet count >= 100,000/uL (transfusion independent, defined as not receiving platelet transfusions within a 7 day period prior to enrollment) for patients with solid tumors without bone marrow involvement
146.0
For patients with solid tumors without known bone marrow involvement:* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3* Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)* Hemoglobin >= 8.0 g/dl at baseline (may receive red blood cell [RBC] transfusions)
51.0
For patients with solid tumors without known bone marrow involvement:* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3* Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
49.0
For patients with solid tumors without known bone marrow involvement:* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3* Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
98.0
For patients with solid tumors without known bone marrow involvement:* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3* Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
49.0
For patients with solid tumors without known bone marrow involvement:* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3* Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
49.0
For patients with solid tumors without known bone marrow involvement:* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3* Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
144.0
For patients with solid tumors without known bone marrow involvement:* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3 within 7 days prior to enrollment * Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment)
49.0
GENERAL INCLUSION CRITERIA FOR SUBPROTOCOLS: For patients with solid tumors without known bone marrow involvement:* Peripheral absolute neutrophil count (ANC) >= 1000/mm^3* Platelet count >= 100,000/mm^3 (transfusion independent, defined as not receiving platelet transfusions for at least 7 days prior to enrollment
1500.0
